Founded In March 2018China Immunotechbeijingbiotechnology Coltdis Dedicated To Biopharmaceutical Research And Developmentwe Focus On Developing And Commercializing The Products Of Cellular Immunotherapy For Cancer And Other Diseasesthe Star T And Tcr T Are The Two Unique Core Technological Platforms Developed By Our Companyour Founder And Leading Scientistdrxin Linis An Immunologist And Professor At Tsinghua University In Beijingchinaour Company Is A Successful Model Of The Translation Of Scientific And Technological Achievements At Tsinghua Universitybased On The Unique Core Technologiesmature Developing Techniquesquality Controlled Industrial Platformsand Wide Range Clinical Cooperationour Company Has Filed And Launched Sevenfirst In Humanclinical Studieswe Have Already Successfully Treated More Than 20 Patients Using Our Tcr T Star T Car T Cell Transfusion Therapythe Clinical Study Data Provided Very Positive Evidences About Safety And Effectiveness Of The Treatmentssome Projects Are In The Process Of Applying For New Drug Ind With Distinctive Features Of Remarkable R&D Advantagestechnology Driven Innovationunique Dual Technology Platformsnumerous Pipelines And Excellent Expansibilitywe Are Pursuing A Strong And Fast Industrializing Goaland Building A Technology Basedhighly Effectivetranslational Medicine Developing Companyby Innovating Science And Fighting Cancerour Mission At China Immunotech Is To Prospect The Future Together With You
